News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
773,704 Results
Type
Article (66991)
Company Profile (439)
Press Release (706254)
Multimedia
Podcasts (157)
Webinars (27)
Section
Business (209307)
Career Advice (2972)
Deals (36977)
Drug Delivery (141)
Drug Development (85539)
Employer Resources (184)
FDA (17519)
Job Trends (16194)
News (359859)
Policy (35968)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2988)
Academic (1)
Accelerated approval (34)
Adcomms (36)
Allergies (148)
Alliances (53105)
ALS (180)
Alzheimer's disease (1796)
Antibody-drug conjugate (ADC) (345)
Approvals (17706)
Artificial intelligence (577)
Autoimmune disease (166)
Automation (39)
Bankruptcy (378)
Best Places to Work (12433)
BIOSECURE Act (23)
Biosimilars (202)
Biotechnology (301)
Bladder cancer (164)
Brain cancer (65)
Breast cancer (667)
Cancer (5051)
Cardiovascular disease (450)
Career advice (2523)
Career pathing (40)
CAR-T (306)
CDC (58)
Celiac Disease (2)
Cell therapy (807)
Cervical cancer (38)
Clinical research (72275)
Collaboration (1841)
Company closure (4)
Compensation (1139)
Complete response letters (73)
COVID-19 (2982)
CRISPR (98)
C-suite (879)
Cystic fibrosis (154)
Data (6328)
Decentralized trials (2)
Denatured (57)
Depression (151)
Diabetes (534)
Diagnostics (7150)
Digital health (47)
Diversity (13)
Diversity, equity & inclusion (47)
Drug discovery (275)
Drug pricing (220)
Drug shortages (33)
Duchenne muscular dystrophy (241)
Earnings (86198)
Editorial (65)
Employer branding (22)
Employer resources (163)
Events (120370)
Executive appointments (1033)
FDA (20725)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (10)
Frontotemporal dementia (24)
Funding (1550)
Gene editing (215)
Generative AI (51)
Gene therapy (656)
GLP-1 (1115)
Government (5233)
Grass and pollen (8)
Guidances (387)
Healthcare (20556)
HIV (60)
Huntington's disease (50)
IgA nephropathy (86)
Immunology and inflammation (292)
Immuno-oncology (62)
Indications (104)
Infectious disease (3269)
Inflammatory bowel disease (202)
Inflation Reduction Act (15)
Influenza (120)
Intellectual property (251)
Interviews (537)
IPO (17351)
IRA (57)
Job creations (4150)
Job search strategy (2084)
JPM (67)
Kidney cancer (16)
Labor market (83)
Layoffs (644)
Leadership (40)
Legal (8712)
Liver cancer (99)
Longevity (15)
Lung cancer (681)
Lymphoma (382)
Machine learning (45)
Management (64)
Manufacturing (841)
MASH (174)
Medical device (14939)
Medtech (14995)
Mergers & acquisitions (20716)
Metabolic disorders (1398)
Multiple sclerosis (165)
NASH (23)
Neurodegenerative disease (357)
Neuropsychiatric disorders (102)
Neuroscience (3125)
Neurotech (1)
NextGen: Class of 2026 (7379)
Non-profit (5025)
Now hiring (59)
Obesity (680)
Opinion (331)
Ovarian cancer (168)
Pain (215)
Pancreatic cancer (234)
Parkinson's disease (301)
Partnered (37)
Patents (510)
Patient recruitment (493)
Peanut (59)
People (62156)
Pharmaceutical (93)
Pharmacy benefit managers (31)
Phase 1 (22629)
Phase 2 (31748)
Phase 3 (23786)
Pipeline (5236)
Policy (331)
Postmarket research (2656)
Preclinical (9939)
Press Release (72)
Prostate cancer (250)
Psychedelics (57)
Radiopharmaceuticals (302)
Rare diseases (923)
Real estate (6563)
Recruiting (75)
Regulatory (26732)
Reports (48)
Research institute (2699)
Resumes & cover letters (474)
Rett syndrome (28)
RNA editing (21)
RSV (85)
Schizophrenia (160)
Series A (259)
Series B (198)
Service/supplier (12)
Sickle cell disease (104)
Special edition (27)
Spinal muscular atrophy (173)
Sponsored (48)
Startups (4070)
State (2)
Stomach cancer (19)
Supply chain (113)
Tariffs (98)
The Weekly (99)
Vaccines (1141)
Venture capital (96)
Weight loss (463)
Women's health (88)
Worklife (22)
Date
Last 7 days (637)
Last 30 days (2234)
Last 365 days (31629)
2026 (3019)
2025 (32110)
2024 (37363)
2023 (42252)
2022 (53611)
2021 (58354)
2020 (57173)
2019 (50463)
2018 (38445)
2017 (35635)
2016 (35442)
2015 (41084)
2014 (33931)
2013 (29568)
2012 (31169)
2011 (31556)
2010 (29220)
Location
Africa (1031)
Alabama (92)
Alaska (7)
Arizona (280)
Arkansas (13)
Asia (46708)
Australia (7881)
California (11530)
Canada (3315)
China (1172)
Colorado (489)
Connecticut (494)
Delaware (347)
Europe (105413)
Florida (1699)
Georgia (374)
Hawaii (4)
Idaho (64)
Illinois (919)
India (68)
Indiana (537)
Iowa (22)
Japan (434)
Kansas (130)
Kentucky (42)
Louisiana (28)
Maine (83)
Maryland (1449)
Massachusetts (8403)
Michigan (337)
Minnesota (654)
Mississippi (6)
Missouri (138)
Montana (35)
Nebraska (29)
Nevada (126)
New Hampshire (85)
New Jersey (3091)
New Mexico (33)
New York (3038)
North Carolina (1582)
North Dakota (10)
Northern California (5559)
Ohio (351)
Oklahoma (23)
Oregon (46)
Pennsylvania (2309)
Puerto Rico (22)
Rhode Island (49)
South America (1391)
South Carolina (67)
South Dakota (1)
Southern California (4481)
Tennessee (175)
Texas (1798)
United States (41292)
Utah (342)
Vermont (1)
Virginia (282)
Washington D.C. (84)
Washington State (964)
West Virginia (4)
Wisconsin (127)
Wyoming (2)
773,704 Results for "centro de imagem diagnosticos".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Care Access Announces Acquisition of Centro Multidisciplinar de Estudos Clínicos (CEMEC), a Leading Brazil-Based Clinical Research Center
March 10, 2025
·
3 min read
Biotech Bay
Injectsense First-in-Human Glaucoma Device Study Approved by Ethics Committee at Centro de la Vision Clinic
Injectsense Inc., a sensor-enabled digital health company, announced that the ethics committee at the Centro de la Vision Clinic in Santiago, Chile, has approved a 20-patient study that will confirm safety and effectiveness of the company’s ultra-miniature wireless pressure sensor, designed to continuously measure intra-ocular pressure (IOP) for glaucoma.
May 6, 2024
·
4 min read
Press Releases
Concept Medical Announces First Patient Enrollment in STARS DAPT Randomized Clinical Trial Evaluating Abluminus NP Polymer-Free DES
January 22, 2026
·
4 min read
Press Releases
Institut du Cancer de Montpellier and TAE Life Sciences Launch AMBER Project to Bring BNCT to France
December 18, 2025
·
3 min read
Press Releases
Bridge to Life™ Secures FDA De Novo Clearance for VitaSmart™ Hypothermic Oxygenated Perfusion (HOPE) System, the First Device Cleared in the U.S. for Hypothermic Oxygenated Perfusion of Donor Livers
January 20, 2026
·
5 min read
Press Releases
AI Proteins Raises $41.5M Series A Financing to Advance De Novo Miniproteins as a New Therapeutic Modality
November 20, 2025
·
3 min read
Press Releases
Nexus Search Partners Places Switzerland-Based Dr. Vinicius Gomes de Lima as Chief Medical Officer at Azurity Pharmaceuticals
November 20, 2025
·
1 min read
Podcast
JPM26 Recap, Novo’s Oral Wegovy Soars as Lilly’s Orforglipron Is Delayed, IPOs Return
The obesity market and Most Favored Nation drug pricing were among the topics de jour at the J.P. Morgan Healthcare Conference last week, while smaller biotechs sought to assure investors that their regulatory ducks are in a row; Novo Nordisk’s oral obesity pill got off to a hot start while the FDA delayed a decision on Eli Lilly’s investigational offering; and SpyGlass Pharma and AgomAb Therapeutics join the 2026 IPO club.
January 21, 2026
·
1 min read
·
Heather McKenzie
Press Releases
Accipiter Biosciences Emerges from Stealth with $12.7 Million in Seed Financing to Deliver de novo Protein Therapies for Complex Diseases
November 6, 2025
·
5 min read
CAR-T
Kyverna’s CAR T Therapy Sets ‘New Efficacy Standard’ in Myasthenia Gravis, De-Risking Phase III Trials
With a 100% response rate in a Phase II study, KYV-101 sets a new efficacy bar in generalized myasthenia gravis, according to analysts at William Blair.
October 30, 2025
·
2 min read
·
Tristan Manalac
1 of 77,371
Next
